Renal artery stenosis is diagnosed through a combination of clinical suspicion and imaging, starting with duplex ultrasound as the first-line screening test and escalating to CT angiography, MR angiography, or conventional angiography depending on the results. No single test is perfect, so diagnosis typically involves matching a patient’s risk profile with one or more imaging studies to confirm narrowing in the arteries that supply the kidneys.
Who Gets Tested
Not everyone with high blood pressure needs screening for renal artery stenosis. Doctors look for specific red flags that suggest the kidneys’ blood supply may be the underlying problem. These include:
- Hypertension before age 30 or severe hypertension developing after age 55
- Resistant hypertension that doesn’t respond to three or more blood pressure medications
- Worsening kidney function after starting ACE inhibitors or ARBs
- Unexplained kidney asymmetry, where one kidney is noticeably smaller than the other
- Flash pulmonary edema, sudden fluid buildup in the lungs without a clear cardiac cause
- Unexplained acute heart failure or multivessel coronary artery disease with refractory angina
The more of these features a patient has, the stronger the case for moving to imaging. A young woman with new-onset hypertension raises suspicion for a condition called fibromuscular dysplasia, while an older patient with widespread atherosclerosis and resistant hypertension points toward plaque-related narrowing.
Duplex Ultrasound: The Starting Point
Duplex ultrasound is the most common first step because it’s noninvasive, doesn’t require contrast dye, and can be repeated safely. The test uses a combination of standard ultrasound imaging and Doppler measurements that track how fast blood is flowing through the renal arteries. Faster flow at a specific point suggests a narrowing, the same way water speeds up when you partially cover a garden hose nozzle.
The two main measurements are peak systolic velocity (PSV) and the renal-aortic ratio (RAR). PSV captures the top speed of blood flow at the narrowest point. Most centers use a threshold of 180 to 200 cm/s to flag a stenosis of 50% or greater, with sensitivities and specificities around 85 to 90% at those cutoffs. A PSV above 285 cm/s points to a tighter narrowing of 60% or more. The RAR compares blood speed in the renal artery to speed in the aorta. A ratio above 3.5 indicates significant stenosis with a specificity as high as 95 to 97%. Combining both measurements improves accuracy to roughly 90% for both sensitivity and specificity.
Ultrasound does have real limitations. It depends heavily on the operator’s skill, and results can be unreliable in patients with obesity, excessive bowel gas, or deep-set kidneys. It also struggles to detect narrowing in smaller accessory renal arteries, which supply about a third of people.
CT Angiography
When ultrasound results are inconclusive or when more anatomical detail is needed before a procedure, CT angiography (CTA) is a common next step. It produces detailed three-dimensional images of the renal arteries and surrounding structures, with sensitivity and specificity both around 90%. CTA is particularly good at identifying the location and extent of narrowing and can reliably catch disease in the main renal arteries.
The trade-off is that CTA requires iodine-based contrast dye, which poses a risk to patients whose kidneys are already compromised. Radiation exposure is another consideration, though modern scanners have reduced doses significantly. For patients with normal or near-normal kidney function, CTA provides an excellent balance of accuracy and speed.
MR Angiography
MR angiography (MRA) offers similar image quality to CTA without radiation, making it an appealing alternative. It uses gadolinium-based contrast agents instead of iodine dye. However, this creates a different safety concern for patients with advanced kidney disease. In patients with very low kidney function (estimated filtration rate below 15 mL/min) or acute kidney failure, gadolinium contrast has been linked to nephrogenic systemic fibrosis, a serious condition involving progressive scarring of the skin, heart, and lungs. Studies have found this complication in roughly 3% of dialysis patients exposed to certain gadolinium agents.
For patients with reasonably preserved kidney function, MRA is a safe and accurate option. Non-contrast MRA techniques also exist, though they sacrifice some image quality. MRA can sometimes overestimate the degree of narrowing, which is worth knowing if your results seem more severe than your symptoms suggest.
Conventional Angiography: The Gold Standard
Digital subtraction angiography (DSA) remains the definitive test. A catheter is threaded through a blood vessel, usually in the groin, and contrast dye is injected directly into the renal arteries while X-ray images are captured. This provides the clearest possible view of the arteries and allows doctors to measure pressure differences across a narrowing in real time. A pressure drop greater than 20 mmHg (or more than 10% of mean arterial pressure) confirms that a stenosis is restricting blood flow enough to matter.
Because it’s invasive and carries risks including bleeding, vessel injury, and contrast-related kidney damage, conventional angiography is generally reserved for cases where noninvasive tests are inconclusive or where treatment (such as stenting) is being planned during the same procedure. It’s not a screening tool but rather the final step when confirmation is needed before intervention.
What Counts as Significant Narrowing
Most experts consider a stenosis of 50 to 60% to be clinically significant, meaning it’s tight enough to trigger excess renin production and drive up blood pressure. However, blood flow and pressure in a large artery don’t actually drop measurably until the narrowing exceeds 70 to 75%. This gap explains why some patients with moderate stenosis on imaging may not benefit from procedures to open the artery. The pressure gradient measurement during angiography helps bridge this gap by showing whether a narrowing is actually restricting flow, not just present on a picture.
Distinguishing the Two Main Causes
Renal artery stenosis has two primary causes, and imaging can usually tell them apart because they affect different parts of the artery. Atherosclerotic stenosis, which accounts for about 90% of cases, involves plaque buildup at the very beginning of the renal artery where it branches off the aorta (the ostial and proximal segment). It typically shows up in older patients with risk factors like diabetes, smoking, and high cholesterol.
Fibromuscular dysplasia (FMD) affects the middle and distal portions of the artery, farther from the aorta. It’s far more common in younger women. On CT or conventional angiography, FMD produces a distinctive “string of beads” pattern created by alternating areas of narrowing and small bulges in the artery wall. This appearance is so characteristic that it can often clinch the diagnosis without further testing.
Nuclear Medicine Tests
Captopril renal scintigraphy (also called a captopril renal scan) was once used to assess whether a narrowed renal artery was actually causing high blood pressure. The test involves giving a blood pressure medication that unmasks reduced blood flow to the affected kidney. However, real-world clinical performance has been substantially worse than early research suggested. Current evidence indicates it should not be used as a screening test for renal artery stenosis, even in patients with a high likelihood of disease. Its role has narrowed to helping decide whether a patient with already-confirmed stenosis might benefit from a procedure to restore blood flow.